ArticleCancers2021
Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma.
Andrew J Wiele et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papertrialcites it
ArticleCancers2021
Andrew J Wiele et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.